Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
|
|
|
- Patrick McKenzie
- 6 years ago
- Views:
Transcription
1 Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017) Participating Drug Company 3M Critical and Chronic Care 3M Drug Delivery Systems 3M Infection Prevention 3M Oral Care AbbVie Inc. ACADIA Pharmaceuticals Inc. Accord Healthcare Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Actavis Generics Actavis Pharma, Inc. (only for labeler code 52544) Actelion Pharmaceuticals US, Inc. Advanced Vision Research Inc. d.b.a. Akorn Consumer Health Aegerion Pharmaceuticals, Inc. Afaxys Inc. Afaxys Pharmaceuticals (a division of Afaxys Inc.) Affordable Pharmaceuticals LLC Akorn Animal Health, Inc. Akrimax Pharmaceuticals, LLC AKRON COATING & ADHESIVES Alcon Laboratories, Inc. Allergan Sales LLC Allergan USA, Inc. Alva-Amco Pharmacal Companies, Inc. AMAG Pharma USA, Inc. AMAG Pharmaceuticals, Inc. Amarin Corp Amarin Corp. PLC Amarin Pharmaceuticals Ireland Ltd. American Regent, Inc. Amerisource Health Services Corporation DBA: American Health Packaging Amgen Inc. Amgen USA Amneal Pharmaceuticals LLC Anchen Pharmaceuticals, Inc. (d/b/a Par Pharmaceutical) ApoPharma USA, Inc. Apotex Corp. Aptalis Pharma US Inc Aptevo BioTherapeutics LLC AbbVie Inc. ACADIA Pharmaceuticals Inc. Accord Healthcare Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Teva Pharmaceuticals USA, Inc. Actelion Pharmaceuticals US, Inc. Aegerion Pharmaceuticals, Inc. Afaxys Inc. Afaxys Inc. Braintree Laboratories Inc. Akrimax Pharmaceuticals, LLC AKRON COATING & ADHESIVES Alva-Amco Pharmacal Companies, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Daiichi Sankyo, Inc. Amerisource Health Services Corporation DBA: American Health Packaging Amgen Inc. Amgen Inc. Amneal Pharmaceuticals LLC Apotex Holdings, Inc. Apotex Holdings, Inc. Aptevo BioTherapeutics LLC King County Producer List Page 1
2 Aqua Pharmaceuticals an Almirall Company AR Scientific, Inc. Arbor Pharmaceuticals Ireland Ltd. Arbor Pharmaceuticals Sales, LLC Arbor Pharmaceuticals, LLC Aristos Pharmaceuticals, Inc. Ascend Laboratories, LLC Astellas Pharma US, Inc. AstraZeneca LP Athena Neurosciences, LLC Aurobindo Pharma Limited AuroHealth, LLC AuroLife Pharma LLC AuroMedics Pharma, LLC Auxilium Pharmaceuticals, Inc. Avadel Pharmaceuticals (USA), Inc. Avanir Pharmaceuticals Aveva Drug Delivery Systems, Inc. B.F. Ascher & Co., Inc. Banner Life Sciences LLC Barr Pharmaceuticals, Inc. Bausch + Lomb Baxalta US Inc. Baxter Healthcare Corporation Bayer Consumer Care Holdings LLC Bayer HealthCare Animal Health Inc. Bayer HealthCare Pharmaceuticals Inc. Bayer HealthCare Pharmaceuticals LLC BestCo, Inc. Biogen Inc. BioMarin Pharmaceutical Inc. BionPharma Inc. Blistex Inc. BluePoint Laboratories BOCA Pharmacals, Inc. Boehringer Ingelheim Animal Health Boehringer Ingelheim Fremont, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Roxane, Inc. Boehringer Ingelheim Vetmedica, Inc. Aqua Pharmaceuticals an Almirall Company Chiesi USA, Inc. (formerly Cornerstone Therapeutics, Inc.) Ascend Laboratories, LLC Astellas Pharma US, Inc. Avadel Pharmaceuticals (USA), Inc. Avanir Pharmaceuticals Apotex Holdings, Inc. B.F. Ascher & Co., Inc. BionPharma Inc. Teva Pharmaceuticals USA, Inc. Valeant Pharmaceuticals International Baxter Healthcare Corporation BestCo, Inc. Biogen Inc. BioMarin Pharmaceutical Inc. BionPharma Inc. Blistex Inc. BluePoint Laboratories King County Producer List Page 2
3 Braintree Laboratories Inc. & Gilead Sciences, LLC Sanofi Pharmaceuticals Holding Partnership C.B. Fleet Company, Inc. C.B. Fleet Company, Incorporated Caraco Pharma, Inc. Celgene Corporation Ceptaris Therapeutics, LLC Ceptaris, LLC Cetylite Industries, Inc. Chattem Chemicals, Inc. Chattem, Inc. Cherokee Pharmaceutical LLC Chiesi USA, Inc. (formerly Cornerstone Therapeutics, Inc.) Church & Dwight Company, Inc. Citron Pharma, LLC. Civitas Therapeutics, Inc. Clarion Brands LLC Clover Pharmaceuticals Corp. Cobrek Pharmaceuticals, Inc. Cody Laboratories Colgate Oral Pharmaceuticals, Inc. Colgate-Palmolive Company Concordia Pharmaceuticals Inc. Cornerstone Therapeutics Inc. CoTherix, Inc. CSL Behring, LLC Cubist Pharmaceuticals CutisPharma, Inc. Cypress Medical Products LLC Daiichi Sankyo, Inc. DAVA Pharmaceuticals, Inc. Depomed, Inc. DePuy Mitek, LLC Dr Reddy's Laboratories, Inc Dr. Reddy's Laboratories Louisiana, LLC Dr. Reddy's Laboratories Tennessee, LLC DSE Healthcare Solutions, LLC Duchesnay Inc. Duchesnay USA, Inc. Dungan Mutual Associates, LLC Durata Therapeutics US Limited DUSA Pharmaceuticals New York, Inc. DUSA Pharmaceuticals, Inc. Dyax Corporation Braintree Laboratories Inc. Gilead Sciences, Inc. C.B. Fleet Company, Inc. Celgene Corporation Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Cetylite Industries, Inc. Sanofi-Aventis US LLC. Chiesi USA, Inc. (formerly Cornerstone Therapeutics, Inc.) Church & Dwight Company, Inc. Citron Pharma, LLC. Acorda Therapeutics, Inc. Clarion Brands LLC Lannett Company, Inc. Colgate-Palmolive Company Colgate-Palmolive Company Concordia Pharmaceuticals Inc. Chiesi USA, Inc. (formerly Cornerstone Therapeutics, Inc.) Actelion Pharmaceuticals US, Inc. CSL Behring, LLC CutisPharma, Inc. Daiichi Sankyo, Inc. Depomed, Inc. Dr Reddy's Laboratories, Inc Dr Reddy's Laboratories, Inc Dr Reddy's Laboratories, Inc DSE Healthcare Solutions, LLC Duchesnay USA, Inc. Duchesnay USA, Inc. King County Producer List Page 3
4 E.R. Squibb & Sons, LLC Edgemont Pharmaceuticals LLC Eisai, Inc. Elan Pharmaceuticals, LLC Eli Lilly and Company EMD Serono, Inc. Eon Labs, Inc. Epic Pharma, LLC Exelixis, Inc. Fera Pharmaceuticals, LLC Ferring Pharmaceuticals Inc. Forest Laboratories LLC (formerly Inc.) Fougera Pharmaceuticals Inc. Foundation Consumer Healthcare, LLC Fresenius Kabi USA, LLC G&W Laboratories, Inc. G&W NC Laboratories LLC G&W PA Laboratories LLC Galderma Laboratories, L.P. Garcoa Laboratories, Inc. GAVIS Pharma LLC GAVIS Pharmaceuticals LLC Genentech USA Genentech, Inc. Generics Bidco I, LLC (d/b/a Par Pharmaceutical) Generics Bidco II, LLC (d/b/a Par Pharmaceutical) Genzyme Corporation Gilead Sciences Limited Gilead Sciences, Inc. GlaxoSmithKline Consumer Healthcare LP Glenmark Pharmaceuticals Inc., USA Greenstone LLC Grifols Biologicals Inc. Grifols Therapeutics Inc.(formerly Talecris Biotherapeutics Inc.) GS Cosmeceutical USA, Inc Gulf South Medical Supply, Inc. Harris Pharmaceutical, Inc. Heritage Pharmaceuticals Inc. Hisamitsu America, Inc. Hi-Tech Pharmacal Co., Inc. Horizon Orphan LLC Horizon Pharma Rheumatology LLC (formerly known as Crealta Pharmaceuticals LLC) Edgemont Pharmaceuticals LLC Eisai, Inc. Eli Lilly and Company EMD Serono, Inc. PuraCap International, LLC Exelixis, Inc. Fera Pharmaceuticals, LLC Ferring Pharmaceuticals Inc. Foundation Consumer Healthcare, LLC Fresenius Kabi USA, LLC G&W Laboratories, Inc. G&W Laboratories, Inc. G&W Laboratories, Inc. Galderma Laboratories, L.P. Garcoa Laboratories, Inc. Hoffman La Roche, Inc. Hoffman La Roche, Inc. Sanofi-Aventis US LLC. Gilead Sciences, Inc. Gilead Sciences, Inc. Glenmark Pharmaceuticals Inc., USA Grifols Shared Services North America Inc. (Formerly Grifols Inc.) Grifols Shared Services North America Inc. (Formerly Grifols Inc.) GS Cosmeceutical USA, Inc Harris Pharmaceutical, Inc. Heritage Pharmaceuticals Inc. Noven Pharmaceuticals, Inc. King County Producer List Page 4
5 Horizon Pharma USA, Inc. Horizon Therapeutics, Inc. Hospira Humco Holding Group, Inc. Humco Holding Group, Inc. HZNP USA, Inc. Immunex Corporation Amgen Inc. Impax Laboratories, Inc. Impax Laboratories, Inc. Incyte Corporation Incyte Corporation Indivior Inc Indivior Inc Ingenus Pharmaceuticals, LLC Ingenus Pharmaceuticals, LLC Innoteq, Inc. (d/b/a Par Pharmaceutical) Insight Pharmaceuticals Corporation Insight Pharmaceuticals LLC Instituto Grifols S.A. Grifols Shared Services North America Inc. (Formerly Grifols Inc.) Intervet, Inc., doing business as Merck Animal Health Ipsen Biopharmaceuticals, Inc Ipsen Biopharmaceuticals, Inc Iroko Pharmaceuticals, LLC Iroko Pharmaceuticals, LLC Jacobus Pharmaceutical Company, Inc. Jacobus Pharmaceutical Company, Inc. Janssen Biotech, Inc. Janssen Pharmaceuticals, Inc. Janssen Products, LP Jazz Pharmaceuticals, Inc. Jazz Pharmaceuticals, plc Jazz Pharmaceuticals, International Division Jazz Pharmaceuticals, plc Consumer, Inc. Jubilant Cadista Pharmaceuticals Inc. Jubilant Cadista Pharmaceuticals Inc. Kadmon Corporation, LLC Kadmon Corporation, LLC Kadmon Pharmaceuticals, LLC Kadmon Corporation, LLC Kaleo Inc. Kaleo Inc. Kowa Pharmaceuticals America Kramer Laboratories Inc. dba Kramer Consumer Health Kramer Laboratories Inc. dba Kramer Consumer Health Kremers Urban Pharmaceuticals Inc. Lannett Company, Inc. Lannett Company, Inc. Lannett Company, Inc. Lehigh Valley Technologies, Inc. Lehigh Valley Technologies, Inc. LEO Pharma A/S LEO Pharma A/S LEO Pharma Inc. LEO Pharma A/S LF Beauty/ Lornamead LF Beauty/ Lornamead Libertas Pharma Inc Mayne Pharma Inc. Lil' Drug Store Products, Inc. Lil' Drug Store Products, Inc. Lornamead Inc. LF Beauty/ Lornamead Luitpold Pharmaceuticals, Inc. Daiichi Sankyo, Inc. Lundbeck LLC Lundbeck LLC Mallinckrodt Pharmaceuticals Mallinckrodt Pharmaceuticals King County Producer List Page 5
6 Matrixx Initiatives, Inc. Mayne Pharma Inc. McKesson Medical-Surgical Inc. McNeil Consumer Healthcare Latin America LLC McNeil Consumer Pharmaceuticals Co. McNeil Healthcare LLC McNeil MMP, LLC McNeil Nutritionals LLC McNeil-PPC, Inc. Mechanical Servants LLC d/b/a Convenience Valet Meda Consumer Healthcare, Inc. Meda Pharmaceuticals, Inc. Medarex, LLC MedImmune Biologics, Inc MedImmune LLC Medtech Products Inc. Mentholatum (China) Pharmaceuticals Co., Ltd. Merck Sharp & Dohme Corp. Meridian Medical Technologies, Inc. Merz North America, Inc. Merz North America, Inc. Merz Pharmaceuticals, LLC Metrics Inc DBA Mayne Pharma Millennium Pharmaceuticals, Inc. (d/b/a Takeda Oncology) Mission Pharmacal Company Mist Pharmaceuticals, LLC Moore Medical LLC Morton Grove Pharmaceuticals, Inc. MSD Consumer Care Inc. Mutual Pharmaceutical Company, Inc. Mylan Institutional Inc. Mylan Institutional LLC Mylan Laboratories Ltd. Mylan Pharmaceuticals, Inc. Mylan Specialty L.P. Nephron Pharmaceuticals Corporation Nephron Pharmaceuticals Corporation - Distribution Center 1 Nephron Pharmaceuticals Corporation - Distribution Center 2 Neutrogena Corporation Nexgen Pharma, Inc. NEXTSOURCE BIOTECHNOLOGY LLC Northstar Rx LLC Novartis Consumer Health, Inc. Matrixx Initiatives, Inc. Mayne Pharma Inc. Mechanical Servants LLC d/b/a Convenience Valet The Mentholatum Company Merz North America, Inc. Merz North America, Inc. Merz North America, Inc. Mayne Pharma Inc. Takeda Pharmaceuticals U.S.A., Inc. Mission Pharmacal Company Mist Pharmaceuticals, LLC Nephron Pharmaceuticals Corporation Nephron Pharmaceuticals Corporation Nephron Pharmaceuticals Corporation Nexgen Pharma, Inc. NEXTSOURCE BIOTECHNOLOGY LLC King County Producer List Page 6
7 Novartis Pharmaceuticals Corporation Novel Laboratories Inc. Noven Pharmaceuticals, Inc. Noven Therapeutics, LLC Novo Nordisk Inc. Numark Brands, Inc. Oak Pharmaceuticals, Inc. Obagi Olta Pharmaceuticals Corp. Onyx Pharmaceuticals Orchid Pharma Ltd. OrchidPharma, Inc. Organon Teknika Corporation, LLC Organon Teknika LLC Ortho-McNeil Finance LLC Otsuka America Pharmaceutical, Inc. Owen Laboratories, Inc. Pacific Pharma, Inc. Paddock Laboratories, LLC Par Pharmaceutical Companies, Inc. Par Pharmaceutical, Inc. Par Pharmaceuticals, Inc. (d/b/a Par Pharmaceutical) Par Sterile Products, LLC (d/b/a Par Pharmaceutical) PARI Respiratory Equipment, Inc. Patriot Pharmaceuticals, LLC PD-Rx Pharmaceuticals, Inc. Pegasus Laboratories, Inc. Perrigo Company of Tennessee Perrigo Corporation Designated Activity Company Perrigo Florida, Inc. Perrigo LLC Perrigo New York, Inc. Perrigo Pharma International Designated Activity Company Perrigo Pharmaceuticals Company Pfizer Consumer Health Pharmacyclics, subsidiary of AbbVie Inc. Pharmalucence, Inc. PL Developments Prestige Brands, Inc. Prestium Pharma, Inc. Primus Pharmaceuticals, Inc. Promius Pharma, LLC Prosolus, Inc. PSS World Medical, Inc. Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Novo Nordisk Inc. DSE Healthcare Solutions, LLC Valeant Pharmaceuticals International Amgen Inc. OrchidPharma, Inc. OrchidPharma, Inc. Otsuka America Pharmaceutical, Inc. Galderma Laboratories, L.P. PARI Respiratory Equipment, Inc. PD-Rx Pharmaceuticals, Inc. Pegasus Laboratories, Inc. AbbVie Inc. PL Developments Primus Pharmaceuticals, Inc. Dr Reddy's Laboratories, Inc Mission Pharmacal Company King County Producer List Page 7
8 PuraCap Caribe PuraCap Laboratories LLC dba Blu Pharmaceuticals PuraCap Pharmaceuticals, LLC Purdue Pharma L.P. Purdue Pharmaceuticals L.P. Purdue Products L.P. Putney, Inc. Quartz Specialty Pharmaceuticals, LLC (d/b/a Par Pharmaceutical) Reckitt Benckiser LLC Renaissance Pharma, Inc. Rhodes Pharmaceuticals L.P. Rohto Pharmaceutical Co. Ltd. Rouses Point Pharmaceuticals, LLC Salix Sandoz Inc. Sanofi Pasteur, Inc. Sanofi-Aventis US LLC. Scios, LLC Sebela Pharmaceuticals Inc. Shionogi Inc. Shire Human Genetic Therapies, Inc. Shire LLC Shire NPS Pharmaceuticals (f/k/a NPS Pharmaceuticals, Inc.) Shire US Inc. Shire US Manufacturing Inc. SigmaPharm Laboratories LLC Sigma-Tau Pharmaceuticals, Inc. Silarx Pharmaceuticals Silvergate Pharmaceuticals, Inc. Sirius Laboratories, Inc. Smith & Nephew Inc (Smith & Nephew Biotherapeutics) Somerset Pharmaceuticals, Inc. Stiefel Laboratories, Inc. Strides Shasun Limited Sunovion Pharmaceuticals Inc. Sunstar Americas, Inc. Supernus Pharmaceuticals, Inc. Takeda Pharmaceuticals America, Inc. Takeda Pharmaceuticals U.S.A., Inc. Talecris Biotherapeutics, Inc. Taro Pharmaceuticals U.S.A., Inc. Tec Laboratories, Inc. TESARO, Inc. Teva Neuroscience Inc. PuraCap International, LLC PuraCap International, LLC PuraCap International, LLC Purdue Pharma L.P. Purdue Pharma L.P. Purdue Pharma L.P. Putney, Inc. Reckitt Benckiser LLC Purdue Pharma L.P. The Mentholatum Company Rouses Point Pharmaceuticals, LLC Valeant Pharmaceuticals International Sanofi-Aventis US LLC. Sanofi-Aventis US LLC. Sebela Pharmaceuticals Inc. Shionogi Inc. SigmaPharm Laboratories LLC Sigma-Tau Pharmaceuticals, Inc. Lannett Company, Inc. Silvergate Pharmaceuticals, Inc. Smith & Nephew Inc (Smith & Nephew Biotherapeutics) Strides Shasun Limited Sunovion Pharmaceuticals Inc. Sunstar Americas, Inc. Supernus Pharmaceuticals, Inc. Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Grifols Shared Services North America Inc. (Formerly Grifols Inc.) Tec Laboratories, Inc. TESARO, Inc. Teva Pharmaceuticals USA, Inc. King County Producer List Page 8
9 Teva Pharmaceuticals USA, Inc. The Mentholatum Company The Procter & Gamble Company The Procter & Gamble Manufacturing Company The Ritedose Corporation (TRC) Theratechnologies Inc. Trigen Laboratories, LLC UCB Inc. Unichem Laboratories Limited Unichem Laboratories Limited United Research Laboratories, Inc. Upsher-Smith Laboratories, Inc. Upstate Pharma LLC URL Pharma, Inc. URL PharmPro, LLC Valeant Pharmaceuticals International Validus Pharmaceuticals LLC Versapharm, Incorporated Vertex Pharmaceuticals Incorporated Vertical Pharmaceuticals, LLC ViiV Healthcare Company Vi-Jon, Inc. Vintage Pharmaceuticals, Inc. (d/b/a Par Pharmaceutical) Vintage Pharmaceuticals, LLC (d/b/a Par Pharmaceutical) Vintage Pharmaceuticals, LLC (d/b/a Par Pharmaceutical) ViroPharma Biologics Inc. Virtus Pharmaceuticals OpCo II, LLC Virtus Pharmaceuticals, LLC Vistakon Pharmaceuticals, Inc. VIVUS BV (Netherlands) Vivus International Limited (Ireland) Vivus International, L.P. (Bermuda) Vivus Limited (Bermuda) VIVUS UK Limited (United Kingdom) Wallace Pharmaceuticals, Inc. Warner Chilcott (US), LLC Watson Laboratories Inc. (only for labeler code 52544) WellSpring Pharmaceutical Corporation West-Ward Pharmaceuticals (A Hikma Company) Wilshire Pharmaceuticals Inc. Wisconsin Pharmacal Company, LLC Wockhardt Limited Teva Pharmaceuticals USA, Inc. The Mentholatum Company The Procter & Gamble Company The Procter & Gamble Company The Ritedose Corporation (TRC) Theratechnologies Inc. Trigen Laboratories, LLC UCB Inc. Upsher-Smith Laboratories, Inc. UCB Inc. Valeant Pharmaceuticals International Validus Pharmaceuticals LLC Vertex Pharmaceuticals Incorporated Trigen Laboratories, LLC Vi-Jon, Inc. Virtus Pharmaceuticals, LLC Virtus Pharmaceuticals, LLC WellSpring Pharmaceutical Corporation West-Ward Pharmaceuticals (A Hikma Company) Wisconsin Pharmacal Company, LLC King County Producer List Page 9
10 XenoPort, Inc. X-GEN Pharmaceuticals, Inc. Xttrium Laboratories, Inc. Zee Medical, Inc. Zoetis Zydus Pharmaceuticals USA Inc ZymoGenetics, Inc. X-GEN Pharmaceuticals, Inc. Xttrium Laboratories, Inc. Zoetis Zydus Pharmaceuticals USA Inc King County Producer List Page 10
Forest Laboratories, Inc. Bristol-Myers Squibb Company
P Number P1001 P1002 P1003 P1009 P1014 P1149 P1004 P1176 P1005 P1006 P1057 P1007 P1008 P1010 P1011 P1012 P1013 P1082 P1128 P1015 P1125 P1170 P1017 P1018 P1019 P1022 P1023 P1024 Manufacturer Name Forest
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION) Feedback from 797 patient groups in Europe PUBLISHED APRIL 2016 The perception [of pharma] has changed in the last years,
Table of contents. Executive Summary. Chapter 1 Introduction. Chapter 2 Trends in monoclonal antibody dealmaking
Table of contents Executive Summary Chapter 1 Introduction Chapter 2 Trends in monoclonal antibody dealmaking 2.1. Introduction 2.2. Monoclonal antibody partnering over the years 2.3. Bigpharma monoclonal
Corporate Reputation of Pharma in 2017 the Patient Perspective
PRESS RELEASE: 'Corporate Reputation of Pharma in - the Global Patient Perspective' Corporate Reputation of Pharma in the Patient Perspective EMBARGOED PRESS RELEASE: 6AM GMT, THURSDAY, APRIL 5TH 2018
2011 Participating Manufacturer Labeler Codes
Acton Pharmaceu.cals, Inc. 1/1/11 1/1/11 Incyte Corpora.on 1/1/11 1/1/11 Rosemont Pharmaceu.cals Limited 1/1/11 1/1/11 Solvay Biologicals 1/1/11 1/1/11 00002 Eli Lilly and Company 1/1/11 1/1/11 00003 E
Pharmaceuticals and Product Stewardship. Sierra Fletcher Product Stewardship Institute April 29, 2011
Pharmaceuticals and Product Stewardship Sierra Fletcher Product Stewardship Institute Who is the Product Stewardship Institute? Non profit founded in 2000 Membership 47 States 200+ Local governments 70+
Full-Disclosure Form
Neuroscience Education Institute Full-Disclosure Form 1930 Palomar Point Way, Ste. 101 Carlsbad, CA 92008 Tel 760-931-8857 Fax 760-931-8713 NEI requires all planners, teachers/speakers, and authors/content
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES PUBLISHED MAY 2016 Dans notre domaine de maladies rares où des efforts ont été faits pour
Online Disclosure Form Submission
Online Disclosure Form Submission Full-Disclosure Form NEI requires all planners, teachers/speakers, and authors/content developers involved with CME content to disclose all financial relationships with
Code of Conduct Interfarma Review 2012
Code of Conduct Interfarma Review 2012 Segundo Congreso Latinoamericano de Compliance de la Industria Farmacéutica e Insumos para la Salud, y el Foro de Buenas Prácticas Interfarma has a cooperation agreement
LABELER CODE LABELER NAME EFF. DATE TERM DATE ELI LILLY AND COMPANY 1/1/ E.R. SQUIBB & SONS, LLC. 1/1/ HOFFMANN-LA ROCHE
00002 ELI LILLY AND COMPANY 1/1/1991 00003 E.R. SQUIBB & SONS, LLC. 1/1/1991 00004 HOFFMANN-LA ROCHE 1/1/1991 00006 MERCK & CO., INC. 1/1/1991 00007 GLAXOSMITHKLINE 1/1/1991 00008 WYETH LABORATORIES 1/1/1991
CMS labelers with signed rebate agreement as of 02_14_18
00002 ELI LILLY AND COMPANY 00003 E.R. SQUIBB & SONS, LLC. 00004 HOFFMANN-LA ROCHE 00006 MERCK & CO., INC. 00007 GLAXOSMITHKLINE 00008 WYETH LABORATORIES 00009 PFIZER, INC 00013 PFIZER, INC. 00015 MEAD
GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES FOR PROTEIN DRUGS
GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES FOR PROTEIN DRUGS BIO021E May 2016 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-288-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
CMO QUALITY OVERSIGHT & RISK MANAGEMENT SUMMIT 4 TH EXECUTIVE SUMMARY
EXECUTIVE SUMMARY 4 TH CMO Strategic Insights on Drug Development Outsourcing to a Contract Manufacturing Organization in an Evolving Regulatory Landscape QUALITY OVERSIGHT & RISK MANAGEMENT SUMMIT CONTENTS
USP Packing General Chapters <661.1>, <381>, <665>: An Industry Perspective on Elemental Impurities Compliance for Container/Closure
USP Packing General Chapters , , : An Industry Perspective on Elemental Impurities Compliance for Container/Closure Tim Shelbourn Co-chair, IQ Consortium ICH Q3D Compliance Working Group
List of Manufacturers with Federal Rebates as of November 20, End Date
List of Manufacturers with Federal Rebates as of November 20, 2018 Labeler Labeler Name 00002 ELI LILLY AND COMPANY 00003 E.R. SQUIBB & SONS, LLC. 00004 HOFFMANN-LA ROCHE 00006 MERCK & CO., INC. 00007
Dir Analytical Dev. Sr Stability & Regulatory Scientist. Quality Control Sr Mgr. Principal Scientist
TITLE COMPANY Dir Analytical Dev Patheon Assoc Dir Quality Control Boehringer Ingelheim Sr Stability & Regulatory Scientist GlaxoSmithKline Quality Control Sr Mgr Sr Analytical Chemist Mallinckrodt Technical
DPW-Pharmacy Division Page B
00002 ELI LILLY AND COMPANY 00132 C B FLEET COMPANY, INC. 00003 E.R. SQUIBB & SONS, INC. 00135 GLAXOSMITHKLINE 00004 HOFFMAN-LA ROCHE INC. 00143 WEST-WARD PHARMACEUTICAL CORP. 00005 LEDERLE LABORATORIES
Exhibitor Prospectus + Advertising and Awareness Opportunities
+ National Meeting and Expo 2018 Exhibitor Prospectus + Advertising and Awareness Opportunities The 2018 Innovatix + Essensa National Meeting & Expo is the only event that provides access to Innovatix
Asia Pac Compliance Code and APEC Principles and Nanjing Declaration Updates - Healthier China Through Innovation
Asia Pac Compliance Code and APEC Principles and Nanjing Declaration Updates - Healthier China Through Innovation Henry Li, General Counsel, RDPAC Beijing, China About RDPAC: R&D based Pharmaceutical Association
GLOBAL MARKETS FOR BIOENGINEERED PROTEIN DRUGS
GLOBAL MARKETS FOR BIOENGINEERED PROTEIN DRUGS BIO009G January 2017 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-417-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION) Feedback from 147 Nordic patient groups PUBLISHED JUNE 2016 Syöpälääkkeiden kehitys on ollut hyvä, ja yhä useammat paranevat.
Datamonitor Healthcare Pharma intelligence informa Datamonitor Healthcare Content Calendar
Datamonitor Healthcare 2017 Datamonitor Healthcare Content Calendar 2017 Content Calendar Published February 2017 Datamonitor Healthcare provides up-to-date insights and analysis that you can trust. Disease
TABLE OF CONTENTS. Executive Summary. Chapter 1 Introduction. Chapter 2 Trends in option and evaluation dealmaking
TABLE OF CONTENTS Executive Summary Chapter 1 Introduction Chapter 2 Trends in option and evaluation dealmaking 2.1. Introduction 2.2. Difference between option and evaluation deals 2.2.1. Types of option
DPW-Pharmacy Division Page B
00002 ELI LILLY AND COMPANY 00131 SCWARZ PHARMA LLC 00003 E.R. SQUIBB & SONS, INC. 00132 C B FLEET COMPANY, INC. 00004 HOFFMAN-LA ROCHE INC. 00135 GLAXOSMITHKLINE 00005 LEDERLE LABORATORIES 00143 WEST-WARD
BIOPHARMACEUTICALS A GLOBAL MARKET OVERVIEW
BIOPHARMACEUTICALS A GLOBAL MARKET OVERVIEW The study reviews, analyzes and projects the global market for Biopharmaceuticals for the period 2006 2015 PUBLISHED: APRIL 2010 Report Code: BT001 Pages: 240
The Novasecta European MidPharma Report 2016
The Novasecta European MidPharma Report 2016 Working closely with such companies for over a decade has provided us with a unique perspective and a substantial body of practical insight into how pharmaceutical
GDUFA Past & Present
GDUFA Past & Present David R. Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory Affairs Generic Pharmaceutical Association June 15, 2015 About GPhA GPhA represents the manufacturers and distributors
April 13, Dear Sir or Madam:
April 13, 2016 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane Room 1061 Rockville, MD 20852 Re: DOCKET Nos. FDA-2015-P-5022
GLOBAL MARKETS FOR DRUG REPURPOSING
GLOBAL MARKETS FOR DRUG REPURPOSING PHM175A January 2016 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-202-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
SUPERGENERICS BIOSIMILARS Biosimilars (Continued) TABLE 3 BIOLOGICS FACING THE LAUNCH OF BIOSIMILARS,
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 2 MARKET ANALYSES AND FORECASTS... 2 METHODOLOGY... 2 INTENDED AUDIENCE... 3 INFORMATION
Product Overview: Global Life Sciences Survey. One Firm. Complete Solutions.
Product Overview: Global Life Sciences Survey One Firm. Complete Solutions. Unmatched Life Sciences Expertise 59 Reporting Countries 812 Participating Organizations 1,900 Unique Jobs Surveyed 390 Thousand
CDISC ST R MEMBERSHIP April 2018
Amgen Boehringer Ingelheim Pharmaceuticals Bristol Myers Squibb Certara CompleWare Corporation Duke Clinical Research Institute Eli Lilly and Company GlaxoSmithKline IQVIA Johnson & Johnson Merck & Co.,
Generic Series: Optimizing Brand Lifecycle Management
A Datamonitor report Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition Published: Jun-08 Product Code: Providing you
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS PUBLISHED OCTOBER 2016 [Question to respondents: Which companies have the best record
Evaluate Data Kit Pharma, Biotech and Medtech, May 2018
Evaluate Data Kit Pharma, Biotech and Medtech, May 2018 Contents Introduction 2 Sourcing Instructions / About Evaluate 3 Section 1 Pharma Industry Overview Top 15 Rx and OTC Sales 4 WW Rx and OTC Sales
Institutional Equities
Sector Update Institutional Equities Pharmaceutical Sector 19 June 2017 Enough Headroom To Grow For Indian Generic Companies Indian generic companies have scaled up their business in the US over the past
MEDIUS PARTNERING. July Global specialist provider of Business Development services to the Pharmaceutical and Healthcare Sectors
MEDIUS PARTNERING July 2017 Global specialist provider of Business Development services to the Pharmaceutical and Healthcare Sectors Medius Associates Healthcare Business Development consultancy founded
Midwest Product Stewardship Council (MPSC) Cynthia Moore
Midwest Product Stewardship Council (MPSC) Cynthia Moore Recycling Program Coordinator Recycling and Solid Waste Section Bureau of Waste & Materials Management Wisconsin Department of Natural Resources
PASS-PAES-HTA studies
PASS-PAES-HTA studies A view from academia Nicholas Moore University of Bordeaux Disclosure 2 Conflict of interest statement I & my department have worked or are working with, or have received various
Carbon report SEB Concept Biotechnology
Carbon report SEB Concept Biotechnology Report created on: February 27, 2018 The carbon footprint provides a historic snapshot of the emissions from the equity holdings of the fund. The calculations are
Strategic vision of Pharma Market
Strategic vision of Pharma Market Evolution 2012-2016 ACIP Presentation, Paris January 30, 2013 Introduction This presentation draws strategic orientations for pharma companies considering the expected
France Pharma RepTrak 2017
France Pharma RepTrak 2017 The World s Most Reputable Pharmaceutical Companies in France Olivier Forlini, Director Reputation Institute France June 2017 1 Why Measure Reputation? The success of your company
Global Oncology Biosimilars Market
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oncology Biosimilars Market 2016-2020 Global Oncology Biosimilars Market 2016-2020 Publication ID: TNV0216071
Representing Healthcare Distribution in Canada
Representing Healthcare Distribution in Canada OUR VISION Ensuring safe, secure, and timely access to life-saving medicines and quality healthcare products for every Canadian. OUR COMMITMENT IMPLEMENTING
WADOH Pharmaceutical Drug Wholesaler Licensee A & Z Pharmaceuticals PA
A & Z Pharmaceuticals PA A & Z Pharmaceuticals PA A.R. Medicom Inc (USA) GA AB Technology WA AB Technology WA Abbott Laboratories NC Abbott Laboratories Shipper's Warehouse TX AbbVie Endocrinology, Inc
The Impact of Secondary Innovation on Firm Market Value in the Pharmaceutical Industry. By: Maitri Punjabi
The Impact of Secondary Innovation on Firm Market Value in the Pharmaceutical Industry By: Maitri Punjabi Honors Thesis Economics Department The University of North Carolina at Chapel Hill March 2016 Approved:
Parameters of Development - Drug Delivery Enabled/Enhanced Products (DDEP ) A Review (Chapter 7)
CHAPTER 7 FDA DRUG APPROVALS, 2000-2010 Introduction This chapter reviews drug delivery enabled/enhanced product approvals by the FDA over the period 2000-2010. This is a simple analysis that provides
2007 M E DIA PLAN N E R
2007 MEDIA PLANNER The Content OUR MISSION For more than 35 years, Pharmaceutical Representative has been the industry s leading source of ongoing sales insight and development. It provides the essential
Twenty Years of TRIPS Agreement: What Difference Did Product Patent Protection Make to the Pharmaceutical Industry in India?
Twenty Years of TRIPS Agreement: What Difference Did Product Patent Protection Make to the Pharmaceutical Industry in India? Sudip Chaudhuri Indian Institute of Management Calcutta International Workshop
Pharmaceutical Companies and Social Media: Developing New Strategies
Pharmaceutical Companies and Social Media: Developing New Strategies Jena Cutie jena@saaraams.com Karthika Karindalam karthika@saaraams.com 1 2 3 Executive Summary Best Practices and Strategies Pharma
Montagna Symposium on the Biology of Skin
2017 Sustaining Members Curtis T. Thompson, M.D. & LLC Novartis Pharmaceuticals Corporation Procter & Gamble Company Valeant Pharmaceuticals International, Inc. The Company of Biologists The David M.C.
GLOBAL PHARMA INDUSTRY
www. Advancing Development & Manufacturing CONNECTING THE GLOBAL PHARMA INDUSTRY SINCE 1977 2015 M E D I A PLANNER BRANDING Advancing Development & Manufacturing Pharmaceutical Technology Expert Insight.
MARKET INSIGHT BRANDED & GENERIC SPECIALTY PHARMA
MARKET INSIGHT BRANDED & GENERIC SPECIALTY PHARMA www.bourne-partners.com November 2018 INTRODUCTION MARKET UPDATE AND M&A FOCUS The specialty pharmaceutical industry has seen a lot of major developments
BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
: TECHNOLOGIES AND GLOBAL MARKETS BIO061C April 2014 Jackson Highsmith Project Analyst ISBN: 1-56965-801-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within
Best-in-Class Pharma Strategy. Crafting. Data. Concepts. Methods. Tools. Smart Pharma Consulting Expertise. March Smart Pharma Consulting
Best-in-Class Pharma Strategy Data Crafting Concepts Methods Tools Smart Pharma Consulting Expertise March 208 Smart Pharma Consulting Table of Contents Smart Pharma Expertise p.3 3. Strategy Crafting
Will payer leverage and post-election optimism shift dealmaking into a higher gear?
EY M&A Outlook and Firepower Report 2017 Will payer leverage and post-election optimism shift dealmaking into a higher gear? Payer pressure is growing across a wide spectrum of the health care sector.
Patients are Counting on Us: It s Time to Act
Patients are Counting on Us: It s Time to Act Brian Johnson Chairman Rx-360 Senior Director Supply Chain Security Pfizer, Inc. 24 th Global GS1 Healthcare Conference October 2, 2013 THE WALL STREET JOURNAL
IMPROVING TALENT ACQUISITON OUTCOMES
IMPROVING TALENT ACQUISITON OUTCOMES Harry Griendling Founder & CEO March, 2017 2017 DoubleStar, Inc. Proprietary work product. Reproduction or external distribution without prior permission is strictly
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION) Feedback from 108 Spanish patient groups PUBLISHED MAY 2016 Nuevos tratamientos con precios que impidan el acceso para
CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
CENTRAL NERVOUS SYSTEM (CNS) : TECHNOLOGIES AND GLOBAL MARKETS BIO074C March 2016 Jackson Highsmith Project Analyst ISBN: 1-62296-246-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V
Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V Abstract: Indian pharmaceutical industry has proved manufacture of global quality pharmaceutical products
August Teligent, Inc. Jason Grenfell-Gardner CEO Jenniffer Collins CFO. NASDAQ Global Select: TLGT
August 2016, Inc. Jason Grenfell-Gardner CEO Jenniffer Collins CFO NASDAQ Global Select: TLGT Safe Harbor Statement Except for historical facts, the statements in this presentation, as well as oral statements
Welcome to. January 26, The Mayflower Hotel Washington, DC USA
Welcome to January 26, 2015 The Mayflower Hotel Washington, DC USA Mission Statement Provide a venue for biotechnology/biological product discussion that focuses on relevant CMC issues throughout the lifecycle
Theme Sub-theme Quote / issue. Inconsistency and
Theme Sub-theme Quote / issue Inconsistency and ambiguity Problematic and contradictory use of the term "all". Abbvie's webpage describing their transparency policy says "AbbVie will submit a manuscript
A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director
A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director ITMAT 2010, 27 October 2010 EFPIA Member Companies Participating companies (September 2010):! Innovative
Biotechnology Industry and its Prospects Jay Kim
Biotechnology Industry and its Prospects Jay Kim Senior Managing Director M-Venture Investment www.m-vc.co.kr 1. Biotechnology 2. Biotechnology industry - classification - major markets - bio drug / Genentech
A PHARMA MATTERS REPORT.
Image Copyright: REUTERS/Felix Ausin Ordonez MOVERS AND SHAKERS A PHARMA MATTERS REPORT. July September 2009 The Thomson Reuters quarterly report on the US generics industry using strategic intelligence
TODAY LETTER DATED
TODAY DATED 08.05.2018 PERTAINING TO MISC S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. MEENAKSHI MISSION HOSPITAL & RESEARCH CENTRE 13542 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. IMAGING
Annual Meeting of Stockholders
Annual Meeting of Stockholders May 20, 2015 Jason Grenfell-Gardner President and CEO Jenniffer Collins Chief Financial Officer NYSE MKT: IG Safe Harbor Statement Except for historical facts, the statements
Montagna Symposium on the Biology of Skin
2016 Sustaining Members Anacor Pharmaceuticals, Inc. Galderma International Amgen USA Curtis T. Thompson, M.D. & LLC The David M.C. Ju Foundation Johnson & Johnson Consumer Inc. Tioga Pharmaceuticals,
Sponsorship & Branding opportunities
Learn. Connect. Optimize. Tuesday, June 26, 2018 Hyatt regency Hotel, New Brunswick, New Jersey education Forums networking keynote speaker Sponsorship & Branding opportunities Limited Sponsorships available!
Montagna Symposium on the Biology of Skin
2014 Sustaining Members The Estée Lauder Companies, Inc. Galderma International Advancing Innovation in Dermatology, Inc. DUSA Pharmaceuticals, Inc. Johnson & Johnson Consumer & Personal Products Worldwide
2018 M&A Firepower Report 1
2018 M&A Firepower Report 1 2018 M&A Firepower Report: Life Sciences Deals and Data 2018 M&A Firepower Report 2 With disruptors at the gates, how will you secure your company s future? What lessons does
Clinical Trials in Ukraine Orange Paper Annual Summary
Orange Paper 2016 Annual Summary CRO Synergy Group Ukraine 48/50, Volynska str., Kyiv, 03151, Ukraine www.synrg-pharm.com Contents Executive Summary... 3 Clinical Trials by Type... 4 Figure 1. Clinical
Actively helping to shape the digital transformation in the health care system.
Actively helping to shape the digital transformation in the health care system. Five recommendations by the vfa for an innovation-friendly enabling policy Five recommendations by the vfa for involving
March Teligent, Inc. Jason Grenfell-Gardner President and CEO Jenniffer Collins Chief Financial Officer. NASDAQ Global Select: TLGT
March 2016, Inc. Jason Grenfell-Gardner President and CEO Jenniffer Collins Chief Financial Officer NASDAQ Global Select: TLGT Safe Harbor Statement Except for historical facts, the statements in this
Presenter. Guy Clark. Searle Pharmaceuticals Sales, Marketing, BD. Business Development Director, IVAX Europe. President, Glenmark Europe
Presenter Guy Clark Searle Pharmaceuticals Sales, Marketing, BD 1992-2001 Business Development Director, IVAX Europe 2001-2005 President, Glenmark Europe 2005-2008 Business Development Consultant 2009-2010
INVEST IN PROFIT PERFORMANCE STABILITY ERFORMANCE INNOVATION DIVER IVERSITY STABILITY PROFIT PERF INNOVATION PROFIT DIVERSITY ST
PROFIT PERFORMANCE STABILITY ERFORMANCE INNOVATION DIVER INVEST IN DIVERSITY STABILITY PROFIT PERF NNOVATION PROFIT DIVERSITY STA STABILITY DIVERSITY INNOVATION CANADA S COMPETITIVE ADVANTAGES IVERSITY
by Dennis van Rooij and Tim van Tongeren
July 10, 2015 DISCIPLINE DRIVES DIGITAL EXCELLENCE IN PHARMA Digital Teams Are Change Agents As Much As They Are Capability Engineers by Dennis van Rooij and Tim van Tongeren EXECUTIVE SUMMARY A new wave
New paths to value creation in pharma
New paths to value creation in pharma In a changing industry, survival increasingly depends on leading in categories and distinctive business capabilities. By Nils Behnke, Michael Retterath, Todd Sangster
LETTERS FOR ISSUE ON
S FOR ISSUE ON 06.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. VMG PHARMACEUTICALS PVT. LTD., C/O. M/S. AXA PARENTERALS LTD., DEHRADUN 26122 APPROVAL COSMETICS DIVISION S.NO.
How the Patient Impacts the Industry: Challenges to Development of Pediatric Medicines
How the Patient Impacts the Industry: Challenges to Development of Pediatric Medicines Speakers: Robert Ternik, Eli Lilly David C. T. Tan, AbbVie Moderators: Skylar Wolfe, Bristol-Myers Squibb Beth Galella,
ijobs Workshop: Drug Development in Biotechnology - Agenda
ijobs Workshop: Drug Development in Biotechnology - Agenda 9:30 9:45AM Introduction and Purpose of the Symposium Janet Alder 9:45 10:15 Overview of the Pharmaceutical Industry Larry Wennogle 10:15 10:25
The 2016 Avoca Report
The 2016 Avoca Report Strategic Partnerships Under Scrutiny: A Renewed Look at the State of Clinical Outsourcing SPONSOR & PROVIDER PERCEPTIONS October 2016 Introduction Each year, The Avoca Group surveys
Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions
Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions Sponsored by the HESI Immunotoxicology Technical Committee Silver Spring, MD 22 October 2013 Objectives of the
Proactively Building a Robust Safety System Pharmacovigilance and Risk Management Strategies Summit
3 rd Annual Conference Proactively Building a Robust Safety System Pharmacovigilance and Risk Management Strategies Summit May 25-26, 2016 - Hyatt at The Bellevue, Philadelphia. Conference In Numbers 20+
VALUE IN HEALTH 14 (2011) A215 A222 ISPOR 16TH ANNUAL INTERNATIONAL MEETING FINANCIAL DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS
VALUE IN HEALTH 14 (2011) A215 A222 A215 ISPOR 16TH ANNUAL INTERNATIONAL MEETING FINANCIAL DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS The International Society for Pharmacoeconomics and Outcomes
Public private partnerships to encourage patient access
Public private partnerships to encourage patient access 5 th SFE SFUS Conference Challenges for efficient health care in Central and Eastern Europe Belgrade, 10 th October 2015 How does IMI work? The Innovative
[ BIOPHARMACEUTICALS ] [ BIOPHARMACEUTICALS ] Canada s competitive advantages
![[ BIOPHARMACEUTICALS ] [ BIOPHARMACEUTICALS ] Canada s competitive advantages](/thumbs/89/98878198.jpg "[ BIOPHARMACEUTICALS ] [ BIOPHARMACEUTICALS ] Canada s competitive advantages")
[ BIOPHARMACEUTICALS ] [ BIOPHARMACEUTICALS ] Canada s competitive advantages CANADA S PHARMACEUTICAL SECTOR Canada offers a dynamic and innovative environment for pharmaceutical companies, with first-rate
The Drug Industry: Pharmaceuticals and Biopharmaceuticals
The Drug Industry: Pharmaceuticals and Biopharmaceuticals Presenter Prof. Geoffrey Poitras Simon Fraser University Vancouver, BC Thursday, Jan. 15, 2015 Disclosure Prof. Poitras is a professor of Finance
2016 Clinical Trials Roundup: The Next Generation
2016 Clinical Roundup: The Next Generation Doro Shin Thought Leadership Manager Introduction Welcome to this year s Clinical Roundup where we ll reflect on research initiated in 2016, dissecting the data
Which companies are attending this year?
5 th June 2017 Which companies are attending this year? Note: These are the companies who have given us permission to publish the company name and job title of those who are attending the conference this
Accepted Article. DR ANDREW BLAUVELT (Orcid ID : X) DR LLUÍS PUIG (Orcid ID : )
DR ANDREW BLAUVELT (Orcid ID : 0000-0002-2633-985X) DR LLUÍS PUIG (Orcid ID : 0000-0001-6083-0952) PROFESSOR KRISTIAN REICH (Orcid ID : 0000-0001-5248-4332) Received Date : 07-Sep-2016 Revised Date : 20-Feb-2017
Indian Pharma Global Impact
Indian Pharma Global Impact IIT Alumni Japan Conference Nov 15-17,Tokyo Satish Reddy Managing Director Dr. Reddy s Laboratories Ltd 1 Headlines: TODAY More than three-quarters of the Top 50 pharma companies
PM360 ANNOUNCES WINNERS OF 2016 PHARMA CHOICE AWARDS The Only Healthcare Creative Awards Voted on by the Industry
Press Release For Immediate Release Contact: Andrew Matthius PM360 646-300-8113 PM360 ANNOUNCES WINNERS OF 2016 PHARMA CHOICE AWARDS The Only Healthcare Creative Awards Voted on by the Industry NEW YORK,
Clinical Trials Insight. World Pharmaceutical Frontiers
ABOUT CLINICAL TRIALS INSIGHT The cost of bringing a new drug to market is staggering. Major pharmaceutical companies now invest between $4 billion and $12 billion in developing each new product. Containing
February 7-9, 2012 l Hilton Miami Downtown, Miami FL. Forecasting, Site Selection, Recruitment, Data Integration, and Project Management
Cambridge Healthtech Institute s Third Annual February 7-9, 2012 l Hilton Miami Downtown, Miami FL SUMMIT FOR CLINICAL OPS EXECUTIVES Forecasting, Site Selection, Recruitment, Data Integration, and Project
Personalized healthcare Getting from promise to reality
Personalized healthcare Getting from promise to reality Severin Schwan, CEO Roche Group Swiss-American Chamber of Commerce, 26 August 2009 1 Roche The challenge Personalised healhcare Implementation at
INVESTOR PRESENTATION 2018
INVESTOR PRESENTATION 2018 IMMUNOPRECISE ANTIBODIES, LTD. UNIT 3204-4464 MARKHAM STREET VICTORIA, BRITISH COLUMBIA V8Z 7X8, CANADA IMMUNOPRECISE.COM 1 Disclosures DISCLAIMER This presentation is not, and